Project Title: |
A Phase 2, Open-Label, Basket Study of Atrasentan in Patients with Proteinuric Glomerular Diseases (The AFFINITY Study) |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Hereditary glomerulopathies |
Project Summary: |
To evaluate the effect of atrasentan on proteinuria/albuminuria levels in subjects at risk of progressive loss of kidney function. |
Lead principal investigator(s): |
Marina Vivarelli, Rome |
Co-investigator(s): |
Laura Massella, Rome Chiara Bettini, Rome |
Project Period: |
12/2022 - 12/2060 |
EudraCT Nr.: |
2020-004176-18 |